Emyria Limited: Emyria expands psychiatry advisory to advance psychedelic-assisted therapies and novel MDMA-analogue development

Source :: Plus Company Updates. September 17, 2021
Publication Year :: 2021
Abstract: Sydney, Australia: Emyria Limited has issued the following news release: Consultant general and pain Psychiatrist, Dr. Jeremy Tannenbaum has been appointed to Emyria's clinical advisory to support Emyria's psychedelic-assisted therapy [...]

Subjects :: Ecstasy (Drug) -- Health aspects
Psychotherapy -- Health aspects
Psychiatrists -- Health aspects
General interest
News, opinion and commentary
University of London. Imperial College of Science and Technology

Tools